Table 4.
Virus | ARC | Serum Virus-Specific IgG (Day 0, Diagnostic Assay) |
|||||||
---|---|---|---|---|---|---|---|---|---|
Factor | Corr | p value | R value | Corr | p value | R value | Corr | p value | R value |
G-CSF | ----- | 0.41 | −0.21 | Positive | 0.041 | 0.46 | ----- | 0.74 | 0.08 |
GRO | Negative | 0.025 | −0.56 | ----- | 0.092 | 0.41 | ----- | 0.12 | 0.38 |
IFNγ | ----- | 0.88 | 0.04 | ----- | 0.14 | −0.34 | Negative | 0.006 | −0.59 |
IL-10 | Positive | 0.006 | 0.64 | Negative | 0.011 | −0.55 | Negative | 0.003 | −0.62 |
IP-10 | ----- | 0.099 | 0.41 | ----- | 0.27 | −0.26 | Negative | 0.001 | −0.69 |
TGFα | ----- | 0.42 | −0.22 | Positive | 0.008 | 0.59 | 0.77 | 0.07 |
Legend. Correlations (Corr) were tested using Spearman’s rank-based correlation. Factors (Day 0) for which there was a correlation (p < 0.05) with virus, ARC, and/or virus-specific antibodies (Day 0; virus-specific IgG antibodies were measured with the diagnostic assay) are shown.